Wilson's disease

被引:1002
作者
Ala, Aftab [1 ]
Walker, Ann P.
Ashkan, Keyoumars
Dooley, James S.
Schilsky, Michael L.
机构
[1] Frimley Pk Hosp NHS Fdn Trust, Dept Med, Ctr Gastroenterol & Hepatol, Surrey GU16 7UJ, England
[2] UCL, Royal Free & Univ Coll Med Sch, Div Med, UCL Inst Hepatol, London, England
[3] Natl Hosp Neurol & Neurosurg, Inst Neurol, Sobell Dept Neurosci, London WC1N 3BG, England
[4] New York Weill Cornell Med Ctr, Ctr Liver Dis & Transplantat, New York, NY USA
关键词
D O I
10.1016/S0140-6736(07)60196-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Progressive hepatolenticular degeneration, or Wilson's disease, is a genetic disorder of copper metabolism. Knowledge of the clinical presentations and treatment of the disease are important both to the generalist and to specialists in gastroenterology and hepatology, neurology, psychiatry, and paediatrics. Wilson's disease invariably results in severe disability and death if untreated. The diagnosis is easily overlooked but if discovered early, effective treatments are available that will prevent or reverse many manifestations of this disorder. Studies have identified the role of copper in disease pathogenesis and clinical, biochemical, and genetic markers that can be useful in diagnosis. There are several chelating agents and zinc salts for medical therapy. Liver transplantation corrects the underlying pathophysiology and can be lifesaving. The discovery of the Wison's disease gene has opened up a new molecular diagnostic approach, and could form the basis of future gene therapy.
引用
收藏
页码:397 / 408
页数:12
相关论文
共 118 条
[1]   A clinical and genetic study of 56 Saudi Wilson disease patients: identification of Saudi-specific mutations [J].
Al Jumah, M ;
Majumdar, R ;
Al Rajeh, S ;
Awada, A ;
Al Zaben, A ;
Traif, IA ;
Jumah, ARA ;
Rehana, Z .
EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 (02) :121-124
[2]   Wilson disease in septuagenarian siblings: Raising the bar for diagnosis [J].
Ala, A ;
Borjigin, J ;
Rochwarger, A ;
Schilsky, N .
HEPATOLOGY, 2005, 41 (03) :668-670
[3]  
Alt E R, 1990, Int Rev Exp Pathol, V31, P165
[4]   Treatment of Wilson's disease with zinc. XVIII. Initial treatment of the hepatic decompensation presentation with trientine and zinc [J].
Askari, FK ;
Greenson, J ;
Dick, RD ;
Johnson, VD ;
Brewer, GJ .
JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 2003, 142 (06) :385-390
[5]  
Barthel H, 2003, AM J NEURORADIOL, V24, P234
[6]   Cerebral manifestation of Wilson's disease successfully treated with liver transplantation [J].
Bax, RT ;
Hassler, A ;
Luck, W ;
Hefter, H ;
Krageloh-Mann, I ;
Neuhaus, P ;
Emmrich, P .
NEUROLOGY, 1998, 51 (03) :863-865
[7]   Non-radioactive detection of five common microsatellite markers for ATP7B gene in Wilson disease patients [J].
Bobba, A ;
Marra, E ;
Fathallah, DM ;
Giannattasio, S .
MOLECULAR AND CELLULAR PROBES, 2003, 17 (06) :271-274
[8]   Treatment of Wilson disease with ammonium tetrathiomolybdate - IV. Comparison of tetrathiomolybdate and trientine in a double-blind study of treatment of the neurologic presentation of Wilson disease [J].
Brewer, GJ ;
Askari, F ;
Lorincz, MT ;
Carlson, M ;
Schilsky, M ;
Kluin, KJ ;
Hedera, P ;
Moretti, P ;
Fink, MK ;
Tankanow, R ;
Dick, RB ;
Sitterly, J .
ARCHIVES OF NEUROLOGY, 2006, 63 (04) :521-527
[9]  
Brewer GJ, 2005, CNS DRUGS, V19, P185, DOI 10.2165/00023210-200519030-00001
[10]   Treatment of Wilson's disease with zinc: XV - Long-term follow-up studies [J].
Brewer, GJ ;
Dick, RD ;
Johnson, VD ;
Brunberg, JA ;
Kluin, KJ ;
Fink, JK .
JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1998, 132 (04) :264-278